Find Topic

Healthcare

Is Australia your next best destination for clinical trials?

Australia is home to some of the world’s leading scientists, physicians and healthcare providers. With world-class research capabilities and a thriving biotech sector, the number of clinical trials being conducted in Australia is reportedly growing at around five percent per year, outpacing the United States and the United Kingdom[1]. While Phase III studies have historically…

14 Aug 2018, by Francesca Brewer

Healthcare

Clinical Trials Report Highlights Australia’s Competitive Advantages… And Weaknesses

A 2017 report found that Australia’s clinical trials sector is large. As international competition for clinical trials intensifies, Australian medtech trade group, MTAA, has pledged to work with industry to overcome impediments to conducting trials in the country. To read the full article from Informa Pharma Intelligence, visit: https://medtech.pharmaintelligence.informa.com/MT105181/Clinical-Trials-Report-Highlights-Australias-Competitive-Advantages-And-Weaknesses

24 Jul 2018, by Francesca Brewer

Healthcare

Australia’s Capability in Clinical Trials

Earlier this year, Austrade released the new Clinical Trials industry capability report which highlights why Australia is a leading destination for clinical research of new therapeutic products and medical devices. The report showcases Australia’s strengths in the sector—world-class medical research infrastructure, an efficient regulatory system, a strong and stable business environment, and generous tax incentives—that make it…

24 Jul 2018, by Francesca Brewer

Healthcare

Status Quo or No? 2017 Completed Clinical Trials

A completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots. Company pipeline depictions lack the underlying intelligence that illustrates just how a candidate progressed, or perhaps disappeared altogether from a disease pipeline. As part of our…

13 Jul 2018, by Francesca Brewer

Healthcare | Social Policy

Community exclusion and deviant behaviour

Recent figures indicate that 28 percent of inmates in Australian prisons are Aboriginal, despite Indigenous people making up just 3 percent of the national population. Aunty Kerrie Doyle, Associate Professor of Indigenous Health at RMIT, believes this significant over-representation is due to the ostracism faced by many Indigenous people, both in general society and in…

28 Jun 2018, by Amy Sarcevic

Banking & Finance | Business | Healthcare

Growing the health tech firms of the future – LaunchVic’s bid to provide better access to capital and mentorship

Health technology is Victoria’s fastest growing source of employment, grossing $30 billion per annum for the state; yet, up to 57 per cent of Victorian health-tech start-ups do not know how to access accelerator or investor support - according to a recent report by LaunchVic. The 'State of HealthTech – Victoria' report revealed that, despite…

20 Jun 2018, by Amy Sarcevic

Healthcare

How regulation changes in cosmetic medicine impact the industry

Cosmetic regulatory changes mean more streamlining and less inexperience. So, how will this impact your cosmetic business?   The cosmetic industry is booming. As quick as cosmetic fads come and go these days procedures evolve just as readily to keep up. Non-surgical procedures are more popular than ever; the likes of laser hair removal, injectables,…

2 Jun 2018, by Informa Insights

Healthcare | Legal

Perinatal mortality cases – what can we do better?

  In June 2014 baby Nixon Tonkin died shortly after birth at the Royal Brisbane and Women’s Hospital. Following an induction of labour and approximately two hours of active pushing, obstructed labour was diagnosed and a decision was made to conduct a caesarean section – during which the obstetric registrar encountered significant difficulty in disimpacting…

28 May 2018, by Amy Sarcevic

Healthcare | Technology

What constitutes a strong digital health product?

With more than 300,000 health apps available on google play and itunes, and a proliferation of health technologies recently brought to market, it is fair to say that the last few years have seen a significant amount of hype in the digital health space. But how much of this technology can really be embedded into…

24 May 2018, by Amy Sarcevic

Healthcare

Rethinking morbidity and mortality review meetings in maternity care

In maternity services, morbidity and mortality (M&M) review meetings play a crucial role in reducing avoidable harm, improving transparency and strengthening clinical governance; both locally and across the healthcare system. The process of M&M review allows clinicians to evaluate and reflect on clinical practice and identify areas for improvement, without blame or individual focus. Over…

21 May 2018, by Amy Sarcevic
Page  of 38

Get all the latest on Informa news and events

Informa Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more

Subscribe to Insights
SUBSCRIBE 

Join Our Newsletter
Informa Insights

Stay up-to-date with all the latest
updates, upcoming events & more.
close-link